Updated Guidelines in Treatment of Advanced Colon Cancer

Overview

This course is designed for healthcare professionals seeking to stay abreast of the latest advancements in the treatment of advanced colon cancer. It addresses key knowledge gaps in applying biomarker-driven therapies, selecting optimal treatment sequences, and integrating updated clinical guidelines into personalized care plans. Through case-based learning and interactive sessions, participants will gain the confidence and expertise needed to enhance clinical decision-making and improve patient outcomes.

What I will learn?

• By the end of this session, participants will be able to:
  1. Describe the mechanism of action and rationale for immunotherapy use in advanced colon cancer.
  2. Identify patient subgroups most likely to benefit from immunotherapy, particularly those with MSI-H or dMMR tumors.
  3. Evaluate current clinical evidence supporting the use of checkpoint inhibitors in advanced colon cancer.
  4. Discuss potential adverse effects and management strategies associated with immunotherapy.
  5. Recognize how to Integrate immunotherapy into personalized treatment plans based on biomarker status and disease progression.

Related Classes

• Use of PCSK9i in Very High Risk Patients with Diabetes
• LDL-C Reduction Guidelines and Targets
• Effective Treatment Simplification
• Management of high-risk patients with Diabetes
• Pioneering The Future: Transferring technology and localizing insulin production in Saudi Arabia
• Prevalence of Gram-Positive Resistance Locally and Globally
• Prevalence of CRE Locally and Globally
• Effect of the COVID-19 Pandemic on AMR